Project MIX: Behavioral Intervention to Reduce Risk Among Substance-Using MSM

NCT ID: NCT00153361

Last Updated: 2024-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1686 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-10-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to test the efficacy of an HIV prevention behavioral intervention to reduce sexual risk for HIV infection among non-injection, substance-using men who have sex with men (SUMSM). The primary goal of the intervention is to reduce HIV transmission by reducing the incidence of unprotected anal sex while under the influence of alcohol and other drugs (AOD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Men who have sex with men (MSM) continue to be the largest risk category for incident and prevalent cases of HIV and AIDS in the U.S. Studies of MSM have established an association between alcohol and other drug (AOD) use and risky sexual behaviors. Although studies have assessed and confirmed the association of AOD use and unsafe sex, few have focused specifically on reducing sexual risk of SUMSM.

Sexual risk reduction interventions for MSM identified in the published scientific literature have demonstrated that they are generally effective at reducing sexual risk behaviors among MSM. However, none of these interventions specifically targeted non-injecting SUMSM. Thus, a gap exists in prevention efforts to reduce HIV transmission among SUMSM.

The primary aim of the Project Mix overall is to develop and evaluate a practical intervention strategy that is specifically tailored to the needs of non-injecting SUMSM. The intent of the intervention is to decrease the number of unprotected anal sex partners (and acts) while under the influence of AOD and in general.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Behavioral discussion sessions focused on reducing substance use and sexual risk behavior

Group Type EXPERIMENTAL

Discussion Group

Intervention Type BEHAVIORAL

Comparison

Video discussion on health issues unrelated to HIV prevention and substance use

Group Type ACTIVE_COMPARATOR

Video Discussion Group

Intervention Type BEHAVIORAL

Control

Waitlist control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Discussion Group

Intervention Type BEHAVIORAL

Video Discussion Group

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* be 18 years of age or older;
* self-identify as male;
* understand and read English;
* live within the metropolitan area;
* report being drunk or "buzzed" on alcohol 2 or more times or high on non-injection drugs at least once during (or two hours before) anal sex in the past six months;
* have had at least one unprotected anal sex episode in the past six months with a male partner of unknown or different HIV-status than their own (i.e., DUA)

Exclusion Criteria

* report only marijuana, only Viagra or only marijuana and Viagra use during anal sex (current research shows that marijuana use is not associated with sexual risk behavior);
* report injecting drugs (eligible if only methamphetamine, steroids, hormones and/or prescribed medications) in the past six months;
* have known their HIV-positive status for less than six months (this is done to allow for psychological and behavioral adjustment following an initial HIV diagnosis and this time frame coincides with our screening window); these men (if they so desire) will be put on a wait list and contacted after 6 months have passed since their first HIV-positive test result;
* are currently involved in another HIV behavioral intervention study for MSM \[local study site identifies a list of such studies in their community at the time of the trial\];
* have a specific plan to move from the metropolitan area within the next 15 months;
* participated in the pilot phase of the project;
* other reasons that the investigators deem would make participation either detrimental to the participant or to the study.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

New York Blood Center

OTHER

Sponsor Role collaborator

San Francisco Department of Public Health

OTHER_GOV

Sponsor Role collaborator

University of Illinois at Chicago

OTHER

Sponsor Role collaborator

Health Research Association

OTHER

Sponsor Role collaborator

Gordon Mansergh

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gordon Mansergh

Project Officer/Senior Scientist

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gordon Mansergh, PhD

Role: PRINCIPAL_INVESTIGATOR

Centers for Disease Control and Prevention

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Health Research Association

Hollywood, California, United States

Site Status

San Francisco Department of Public Health

San Francisco, California, United States

Site Status

The University of Illinois at Chicago

Chicago, Illinois, United States

Site Status

Howard Brown Health Center

Chicago, Illinois, United States

Site Status

New York Blood Center

New York, New York, United States

Site Status

Project Achieve

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Mansergh G, Koblin BA, McKirnan DJ, Hudson SM, Flores SA, Wiegand RE, Purcell DW, Colfax GN; Project MIX Study Team. An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group. PLoS Med. 2010 Aug 24;7(8):e1000329. doi: 10.1371/journal.pmed.1000329.

Reference Type DERIVED
PMID: 20811491 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U65/CCU522209

Identifier Type: -

Identifier Source: secondary_id

U65/CCU922215

Identifier Type: -

Identifier Source: secondary_id

U65/CCU222309

Identifier Type: -

Identifier Source: secondary_id

U65/CCU922213

Identifier Type: -

Identifier Source: secondary_id

CDC-NCHSTP-3985

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MI-based PrEP Intervention
NCT03313765 COMPLETED NA